Close

Form 4 HOME BANCSHARES INC For: Oct 26 Filed by: LIEBLONG ALEX R

October 26, 2015 5:44 PM EDT
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
LIEBLONG ALEX R

(Last) (First) (Middle)
P.O. BOX 966

(Street)
CONWAY AR 72033

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HOME BANCSHARES INC [ HOMB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/26/2015
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock - Restricted 10/26/2015   S   50,000 D $ 43.74 587,389 I By Key Colony Fund (hedge fund managing partner)
Common Stock - Restricted               1,666 (1) (2) D  
Common Stock               398,276 D  
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $ 3.5             12/31/2005 12/31/2015 Common Stock 712   712 D  
Stock Option $ 3.92               (3)   (3) Common Stock 1,425   1,425 D  
Stock Option $ 4.21               (4)   (4) Common Stock 2,138   2,138 D  
Stock Option $ 4.92               (5)   (5) Common Stock 2,851   2,851 D  
Stock Option $ 5.33               (6)   (6) Common Stock 3,564   3,564 D  
Stock Option $ 8.6               (7) 01/09/2018 Common Stock 2,376   2,376 D  
Explanation of Responses:
1. Restricted Stock granted on January 18, 2013 will vest in 33 1/3% installments over three years each January 18th.
2. Restricted Stock granted on January 16, 2015 will "cliff" vest 100% three years from award date.
3. The option is exercisable in five equal annual installments. 40% of the issued option is remaining. The first 20% of the remaining option became exercisable on December 31, 2005 and expires on December 31, 2015. The last 20% of the remaining option became exercisable on December 31, 2006 and expires on December 31, 2016.
4. The option is exercisable in five equal annual installments. 60% of the issued option is remaining. The first 20% of the remaining option became exercisable on December 31, 2005 and expires on December 31, 2015. The next 20% of the remaining option became exercisable on December 31, 2006 and expires on December 31, 2016. The last 20% of the remaining option became exercisable on December 31, 2007 and expires on December 31, 2017.
5. The option is exercisable in five equal annual installments. 80% of the issued option is remaining. The first 20% of the remaining option became exercisable on December 31, 2005 and expires on December 31, 2015. The second 20% of the remaining option became exercisable on December 31, 2006 and expires on December 31, 2016. The third 20% of the remaining option became exercisable on December 31, 2007 and expires on December 31, 2017. The last 20% of the remaining option became exercisable on December 31, 2008 and expires on December 31, 2018.
6. The option is exercisable in five equal annual installments. 100% of the issued option is remaining. The first 20% of the remaining option became exercisable on December 31, 2005 and expires on December 31, 2015. The second 20% of the remaining option became exercisable on December 31, 2006 and expires on December 31, 2016. The third 20% of the remaining option became exercisable on December 31, 2007 and expires on December 31, 2017. The fourth 20% of the remaining option became exercisable on December 31, 2008 and expires on December 31, 2018. The last 20% of the remaining option became exercisable on December 31, 2009 and expires on December 31, 2019.
7. The option is exercisable in five equal annual installments and became exercisable on January 10, 2009.
/s/Alex R. Lieblong by Rachel Wesson 10/26/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
                                                                      Exhibit 24

                               POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints
each of Rachel Wesson, LaMonica Johnston, Jennifer Floyd and Brian Davis, signed
singly, the undersigned's true and lawful attorney-in-fact to:

    (1) prepare, execute in the undersigned's name and on the undersigned's
        behalf, and submit to the U.S. Securities and Exchange commission (the
        "SEC") a Form ID, including amendments thereto, and any other documents
        necessary or appropriate to obtain codes and passwords enabling the
        undersigned to make electronic filings with the SEC of reports required
        by Section 16(a) of the Securities Exchange Act of 1934 or any rule or
        regulation of the SEC;
    (2) execute for and on behalf of the undersigned, in the undersigned's
        capacity as an officer and/or director of Home BancShares, Inc. (the
        "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the
        Securities Exchange Act of 1934 and the rules thereunder, and any other
        forms or reports the undersigned may be required to file in connection
        with the undersigned's ownership, acquisition, or disposition of
        securities of the Company;
    (3) do and perform any and all acts for and on behalf of the undersigned
        which may benecessary or desirable to complete and execute any such Form
        3, 4, or 5, or other form or report, and timely file such form or report
        with the United States Securities and Exchange Commission and any stock
        exchange or similar authority; and
    (4) take any other action of any type whatsoever in connection with the
        foregoing which, inthe opinion of such attorney-in-fact, may be of
        benefit to, in the best interest of, or legally required by, the
        undersigned, it being understood that the documents executed by such
        attorney-in-fact on behalf of the undersigned pursuant to this Power of
        Attorney shall be in such form and shall contain such terms and
        conditions as such attorney- in-fact may approve in such attorney-in-
        fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to
be done by virtue of this power of attorney and the rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 17th day of July 2015.


 /s/ Alex R. Lieblong    _
-------------------------
Signature

 Alex R. Lieblong  _
-------------------------
Print Name






 


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings